3 Largecap High Promoter Holding Stocks to Watch for Future Multibagger Potential: LIC, Avenue Supermarts and Zydus Lifesciences

High promoter holding stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. LIC, Avenue Supermarts and Zydus Lifesciences meet that test, with market caps from Rs 1.14 lakh crore to Rs 4.98 lakh crore and LIC offering the highest return on equity at 32.53%. Promoters who own more than 70 per cent of a company have a large personal stake in how well it does.

This list covers large companies with promoter holding above 70 per cent in the latest shareholding pattern and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening high promoter holding stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 16 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are High Promoter Holding Stocks and Why Do They Attract Multibagger Interest?

High promoter holding stocks are shares of companies where the founders, the government or a parent group own the biggest part of the company. A large promoter stake means the people running the business gain most when it grows.

A high promoter holding often signals long-term commitment and stable control. Companies that pair such ownership with rising revenue and profit are the ones investors compare in high promoter holding stocks.

High Promoter Holding Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 16 October 2026. LIC combines the lowest PE of the group, 8.30, with the highest return on equity, 32.53%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Life Insurance Corporation of India	397.75	4,98,410	8.30	10.47	32.53%	0.00	360.75 to 468.48
Avenue Supermarts	3,342	2,20,154	70.67	64.73	11.94%	0.16	3,340.30 to 4,644.00
Zydus Lifesciences	1,123	1,13,790	24.78	36.42	18.59%	0.46	835.50 to 1,232.10

LIC: 93.19% Profit CAGR Since FY22

LIC is India's largest life insurer and one of the biggest institutional investors in the stock market, with a vast agent network across the country. It reported FY26 revenue of Rs 9,90,211.25 crore, up 10.23% year on year, and net profit of Rs 57,453.15 crore, up 18.90%. Net profit has compounded at 93.19% a year since FY22, while revenue has grown 7.96% a year. Operating margin was 5.51% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 6.97% to Rs 2,41,166.45 crore and net profit grew 23.98% to Rs 13,584.25 crore. Domestic institutions raised their holding from 1.36% in September 2025 to 6.17% in September 2026. The stock trades at a PE of 8.30 against an industry PE of 10.47, below the sector average, with a return on equity of 32.53%.

Avenue Supermarts: Profit Compounding at 18.77% a Year

Avenue Supermarts runs the DMart chain of stores that sell groceries and everyday products at low prices. It reported FY26 revenue of Rs 68,894.84 crore, up 15.82% year on year, and net profit of Rs 2,969.86 crore, up 9.69%. Net profit has compounded at 18.77% a year since FY22, while revenue has grown 22.01% a year. Operating margin was 7.07% in FY26. The debt-to-equity ratio is 0.16.

The stock trades at a PE of 70.67 against an industry PE of 64.73. In the September 2026 quarter, revenue rose 17.74% to Rs 19,657.54 crore and net profit grew 8.49% to Rs 742.98 crore. Foreign investors raised their holding from 8.25% in June 2025 to 9.23% in June 2026.

Zydus Lifesciences: 21.24% Profit CAGR Since FY22

Zydus Lifesciences develops and sells generic medicines, vaccines, consumer wellness products and specialty therapies. It reported FY26 revenue of Rs 27,657.90 crore, up 17.64% year on year, and net profit of Rs 5,026.40 crore, up 8.92%. Net profit has compounded at 21.24% a year since FY22, while revenue has grown 15.89% a year. Operating margin was 16.55% in FY26. The debt-to-equity ratio is 0.46.

Revenue for the June 2026 quarter rose 20.72% to Rs 8,123.10 crore, at an operating margin of 25.86%. The share price has gained 113.38% over five years and 15.79% over the past year. Domestic institutions raised their holding from 10.86% in September 2025 to 11.28% in September 2026. The stock trades at a PE of 24.78 against an industry PE of 36.42, below the sector average, with a return on equity of 18.59%.

High Promoter Holding Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these high promoter holding stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
LIC	9,90,211.25	57,453.15	10.23%	7.96%	93.19%	12.00%
Avenue Supermarts	68,894.84	2,969.86	15.82%	22.01%	18.77%	7.16%
Zydus Lifesciences	27,657.90	5,026.40	17.64%	15.89%	21.24%	25.86%

Check the Univest Screener for live data on these high promoter holding stocks

Institutional Holding in LIC, Avenue Supermarts and Zydus Lifesciences

Institutional holding shows who is backing these high promoter holding stocks alongside the promoter. The table uses the latest reported quarter for each. Zydus Lifesciences has the deepest institutional backing, with FII and DII together holding 18.32% as of September 2026. Domestic institutions increased their holding over the past year in LIC (from 1.36% to 6.17%) and Zydus Lifesciences (from 10.86% to 11.28%).

Stock	Promoter	FII	DII	Public	Quarter
LIC	90.00%	1.55%	6.17%	2.28%	September 2026
Avenue Supermarts	74.48%	9.23%	8.74%	7.55%	June 2026
Zydus Lifesciences	75.01%	7.04%	11.28%	6.66%	September 2026

Risks to Weigh in High Promoter Holding Stocks

Being careful with high promoter holding stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• A high promoter stake leaves a smaller free float for trading.
• Decisions of the promoter group can influence the company.
• Valuation: Avenue Supermarts trades at a PE of 70.67 against an industry PE of 64.73, so earnings need to keep growing to support the price.
• Concentration: Holding all 3 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between High Promoter Holding Stocks

Picking from high promoter holding stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (10.47 to 64.73) and ask whether the growth rate justifies any gap.
3. Track the promoter holding, quarterly profit growth and the return on equity in every result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track LIC, Avenue Supermarts and Zydus Lifesciences live prices.

Conclusion

Among high promoter holding stocks, LIC stands out for the highest return on equity at 32.53%, Avenue Supermarts for 15.82% revenue growth in FY26 and Zydus Lifesciences for the biggest five-year price gain at 113.38%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high promoter holding stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on High Promoter Holding Stocks to Watch

Which are the best high promoter holding stocks to watch for multibagger potential?

Ans. LIC, Avenue Supermarts and Zydus Lifesciences are the 3 names this list highlights, with market caps of Rs 4,98,410 crore, Rs 2,20,154 crore and Rs 1,13,790 crore respectively. LIC is notable for the highest return on equity at 32.53%. Avenue Supermarts stands out for 15.82% revenue growth in FY26. Zydus Lifesciences offers the biggest five-year price gain at 113.38%. These are watchlist names for high promoter holding stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is LIC a good stock for long-term investors?

Ans. LIC has a return on equity of 32.53%, a PE of 8.30 against an industry PE of 10.47 and a market cap of Rs 4,98,410 crore. Net profit has compounded at 93.19% a year since FY22, and FY26 revenue rose 10.23% while June 2026 quarter net profit grew 23.98%. Long-term returns in high promoter holding stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Zydus Lifesciences become a multibagger from here?

Ans. Zydus Lifesciences has already gained 113.38% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high promoter holding stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 21.24% a year since FY22, and FY26 revenue rose 17.64%. At a PE of 24.78 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of LIC, Avenue Supermarts and Zydus Lifesciences?

Ans. As of 16 October 2026, LIC has a market cap of Rs 4,98,410 crore, Avenue Supermarts has a market cap of Rs 2,20,154 crore and Zydus Lifesciences has a market cap of Rs 1,13,790 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high promoter holding stocks.

What are the risks of investing in high promoter holding stocks?

Ans. The main risks are a smaller free float, which can make price moves sharper, and the influence of one large shareholder on decisions. Companies with strong governance and steady earnings handle these better. Avenue Supermarts trades at a PE of 70.67 against an industry PE of 64.73, so earnings growth needs to hold up.

Is LIC trading below its industry PE?

Ans. LIC trades at a PE of 8.30 against an industry PE of 10.47. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (net profit has compounded at 93.19% a year since FY22 and FY26 revenue rose 10.23%) and balance sheet strength before drawing a conclusion.

How much do institutions hold in LIC, Avenue Supermarts and Zydus Lifesciences?

Ans. As of the latest reported quarter, FII and DII together hold 7.72% of LIC (1.55% and 6.17%), 17.97% of Avenue Supermarts (9.23% and 8.74%) and 18.32% of Zydus Lifesciences (7.04% and 11.28%). Rising institutional holding is a useful signal in high promoter holding stocks, though it should be read with earnings trends rather than on its own.